The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa

The cephalosporin-β-lactamase-inhibitor-combinations, ceftolozane/tazobactam and ceftazidime/avibactam, have revolutionized treatment of carbapenem-resistant Pseudomonas aeruginosa (CR-PA). A contemporary assessment of their in vitro potency against a global CR-PA collection and an assessment of car...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Christian M., Aktaþ, Elif, Alfouzan, Wadha, Bourassa, Lori, Brink, Adrian, Burnham, Carey-Ann D., Canton, Rafael, Carmeli, Yehuda, Falcone, Marco, Kiffer, Carlos, Marchese, Anna, Martinez, Octavio, Pournaras, Spyros, Satlin, Michael, Seifert, Harald, Thabit, Abrar K., Thomson, Kenneth S., Villegas, Maria Virginia, Nicolau, David P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590662/
https://www.ncbi.nlm.nih.gov/pubmed/34291323
http://dx.doi.org/10.1007/s10096-021-04308-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590662/
https://www.ncbi.nlm.nih.gov/pubmed/34291323
http://dx.doi.org/10.1007/s10096-021-04308-0

Ejemplares similares